Off-target effects of siRNA specific for GFP by Tschuch, Cordula et al.
BioMed  Central
Page 1 of 14
(page number not for citation purposes)
BMC Molecular Biology
Open Access Research article
Off-target effects of siRNA specific for GFP
Cordula Tschuch1, Angela Schulz1, Armin Pscherer1, Wiebke Werft2, 
Axel Benner2, Agnes Hotz-Wagenblatt3, Leticia Serra Barrionuevo1, 
Peter Lichter*1 and Daniel Mertens1,4
Address: 1Division of Molecular Genetics, German Cancer Research Center, Heidelberg, Germany, 2Division of Biostatistics, German Cancer 
Research Center, Heidelberg, Germany, 3Division of Molecular Biophysics, German Cancer Research Center, Heidelberg, Germany and 
4Department of Internal Medicine III, University Hospital, Ulm, Germany
Email: Cordula Tschuch - c.tschuch@dkfz.de; Angela Schulz - a.schulz@dkfz.de; Armin Pscherer - a.pscherer@dkfz.de; 
Wiebke Werft - w.werft@dkfz.de; Axel Benner - benner@dkfz.de; Agnes Hotz-Wagenblatt - hotz-wagenblatt@dkfz.de; 
Leticia Serra Barrionuevo - l.serra@dkfz.de; Peter Lichter* - m.macleod@dkfz.de; Daniel Mertens - d.mertens@dkfz.de
* Corresponding author    
Abstract
Background: Gene knock down by RNAi is a highly effective approach to silence gene expression
in experimental as well as therapeutic settings. However, this widely used methodology entails
serious pitfalls, especially concerning specificity of the RNAi molecules.
Results: We tested the most widely used control siRNA directed against GFP for off-target effects
and found that it deregulates in addition to GFP a set of endogenous target genes. The off-target
effects were dependent on the amount of GFP siRNA transfected and were detected in a variety of
cell lines. Since the respective siRNA molecule specific for GFP is widely used as negative control
for RNAi experiments, we studied the complete set of off-target genes of this molecule by genome-
wide expression profiling. The detected modulated mRNAs had target sequences homologous to
the siRNA as small as 8 basepairs in size. However, we found no restriction of sequence homology
to 3'UTR of target genes.
Conclusion: We can show that even siRNAs without a physiological target have sequence-specific
off-target effects in mammalian cells. Furthermore, our analysis defines the off-target genes affected
by the siRNA that is commonly used as negative control and directed against GFP. Since off-target
effects can hardly be avoided, the best strategy is to identify false positives and exclude them from
the results. To this end, we provide the set of false positive genes deregulated by the commonly
used GFP siRNA as a reference resource for future siRNA experiments.
Background
RNA interference (RNAi) is a powerful method to specifi-
cally suppress gene expression and is therefore widely
used for experimental as well as therapeutic purposes.
Since the initial characterization of RNAi in the nematode
C. elegans [1], the field of RNAi has expanded remarkably.
The essentials of RNAi can be summarized as specific deg-
radation of target mRNA mediated by small, double
stranded RNAs [2,3]. Meanwhile, different mechanisms of
RNAi were discovered in mammalian cells comprising
post-transcriptional gene silencing by siRNAs, transcrip-
tional silencing by siRNAs in the nucleus and the micro-
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RNA pathway [4,5]. It has been shown that exogenously
introduced siRNA duplexes and endogenously processed
miRNA duplexes are taken up by the RNA-induced silenc-
ing complex (RISC). The antisense siRNA (guide strand)
directs RISC to complementary mRNA, while the second
passenger (sense) strand is degraded [6-9].
Recently, the interpretation of RNAi data has become
complicated because several studies reported unintended
interactions between the silencing molecules and cellular
components, so-called off-target effects [10]. Off-target
effects include the induction of the antiviral interferon
pathway machinery and depend on nucleotide sequence
similarity between the siRNA molecule and short motifs
in mRNAs of other genes not intended to be knocked-
down. A source of sequence-dependent off-target effects
in mammals is the high tolerance for mismatches between
the siRNA and the complementary target mRNA outside
of the first 2–8 bases (seed sequence) of the siRNA [11].
Furthermore, off-target effects can be caused by insertion
of the sense siRNA strand into the RISC complex instead
of the antisense strand [12]. Finally, off-target effects can
occur due to seed-sequence-dependent binding [13].
With these off-target effects in mind, we used a commonly
used siRNA sequence directed against GFP in a series of
microarray expression profiling experiments, in which we
knocked down four unrelated candidate suppressor genes
(manuscript in preparation). We carefully analyzed the
resulting data set and could identify a set of genes com-
monly deregulated in all experiments that were unrelated
except for transfection of the GFP siRNA used as negative
control. These commonly deregulated genes were subse-
quently identified as off-target effects of the siRNA against
GFP. Further investigation by expression profiling
revealed the complete set of genes deregulated by the GFP
siRNA.
Results
siRNA specific for GFP specifically targets endogenous 
genes in human cells
In a set of functional experiments, we used RNAi knock
down for the characterization of unrelated candidate sup-
pressor genes in cell lines (manuscript in preparation).
Our experimental procedure resulted in efficient knock
down of up to 87% in HeLa, 87% in U2OS, 72% in HEK
and 68% in EVSAT cells (data not shown). For genome-
wide detection of the resulting transcriptional changes, we
used oligo-microarrays containing 36,196 oligonucle-
otides from 25,100 human genes. As negative control, a
siRNA against GFP was transfected into HEK and HeLa
cells and the resulting RNA co-hybridized in all otherwise
unrelated array experiments. Due to the issue of off-target
effects of siRNA molecules that has been raised recently in
the literature, we carefully analyzed the resulting data for
genes commonly deregulated in all of the experiments.
Indeed, we found a subset of genes to be consistently
deregulated, which we postulated to be in fact deregulated
by the negative control used in all experiments the siRNA
directed against the non-physiological gene GFP. Among
these off-target genes, CYLD and SOAT were most consist-
ently and strongest differentially expressed (Figure 1a).
Expression levels derived from microarray experiments
were normalized as described in Methods or from qPCR
were normalized to 2 housekeeping genes that showed
constant expression levels in all microarray experiments
(PGK, DCTN2). In comparison to these controls, CYLD is
down regulated in HEK and HeLa cells between 1.3 and
2.1 fold, and SOAT is down regulated between 1.9 and 2.5
fold. This statistically significant deregulation (p < 10-11;
Table 1) was confirmed by analysis with quantitative PCR
(Figure 1b) showing a down regulation of CYLD between
1.5 and 3.1 fold (average: 2.2 +/- 0.5) and of SOAT
between 1.3 and 3.2 fold (average: 2.0 +/- 0.6). Besides of
CYLD and SOAT, we analysed the mRNA levels of a set of
off-target genes and found the same effect of down regu-
lation by the GFP siRNA in several more genes (see Addi-
tional file 1). We analyzed the mRNA sequences of CYLD
and SOAT for sequence homology to the sense and anti-
sense siRNA molecule and found 4 and 2 potential target
sites, respectively (data not shown). The control siRNA
against GFP, which we used, is offered by two different
distributors (Table 2 lines 1 & 2). Furthermore a 20 mer
siRNA against GFP differing in only one basepair is dis-
tributed independently (Table 2, line 3). While the off-tar-
get genes might differ between these two GFP siRNAs, the
differences are likely to be small. We characterized the
siRNA directed against GFP as it is frequently used as neg-
ative control in RNAi experiments (Table 2, lines 1 & 2).
Specific off-target effects recur in different cell lines with 
different siRNA molecules
We found specific off-target deregulation of CYLD and
SOAT by GFP siRNA in 3/4 cell lines derived from differ-
ent tissues as compared to mock transfections (Figure 2a).
Only EVSAT cells did not show a reduced expression of
CYLD  and  SOAT, which is probably due to the lower
transfection efficiency (data not shown). In order to
exclude that the observed off-target effects are due to our
preparation of the siRNA, we compared its effects to
chemically synthesized siRNA directed against GFP. While
the sequences of these two molecules are identical, we
used in vitro transcription to produce siRNA, while the
commercially available siRNA was produced by oligonu-
cleotide synthesis. However, transfection of either of these
siRNAs into HEK and HeLa cells resulted in similar
decrease of expression of CYLD and SOAT as compared to
the mock transfection (Figure 2b). We excluded that the
observed effects are due to induction of unspecific inter-
feron response by measuring expression of the OAS1 geneBMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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A siRNA directed against GFP specifically targets endogenous genes in human cells Figure 1
A siRNA directed against GFP specifically targets endogenous genes in human cells. (a) After transfection of the 
control siRNA directed against GFP, underrepresentation of the off-target genes CYLD and SOAT was detected by expression-
microarrays 48 h post-transfection in HEK and HeLa cells. Normalization was performed as described in Additional file 5. (b) 
Verification of underrepresentation of CYLD and SOAT in HEK and HeLa cells by Real-Time PCR using the same mRNA as tem-
plate. Expression of genes was normalized to the median of 2 housekeeping genes (PGK, DCTN2).BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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Table 1: 20 most significantly deregulated genes after transfection of GFP siRNA.
downregulated HELA HEK
# name RefSeq molecular function MX p§ BS MX p§ BS
1 SOAT1 NM_003101 sterol O-acyltransferase activity -2.28 8.72E-14 32.76 -0.83 8.18E-07 14.15
2 Q96HQ8 ~ unknown -1.95 8.72E-14 32.87 -1.52 7.71E-12 27.43
3 CASP8 NM_033356 signal transducer activity;caspase activity -1.56 5.35E-13 30.32 -0.88 6.42E-09 20.37
4 C10orf56 NM_153367 nucleic acid binding;zinc ion binding -1.62 6.03E-13 30.12 -0.49 1.35E-05 10.51
5 NUDT3 NM_006703 magnesium ion binding;hydrolase activity -1.45 1.74E-12 28.78 -0.42 6.64E-05 8.35
6 RAB21 NM_014999 nucleotide binding;GTP binding -1.55 1.89E-12 28.60 -0.76 1.51E-07 16.52
7 HMGCS1 NM_002130 hydroxymethylglutaryl-CoA synthase activity -1.48 2.73E-12 28.09 -0.45 6.05E-05 8.47
8 PAICS NM_006452 catalytic activity;ATP binding -1.37 3.72E-12 27.62 -0.66 3.61E-07 15.39
9 TM16F NM_001025356 integral to membrane -1.59 4.96E-12 27.25 -0.45 2.18E-04 6.68
10 GOSR1 NM_004871 v-SNARE activity -1.47 5.13E-12 27.13 -0.46 6.89E-05 8.29
11 PSF1 NM_021067.3 protein binding -2.18 5.44E-12 27.01 -1.55 5.47E-09 20.81
12 CYLD NM_015247 NFkB pathway -1.39 6.75E-12 26.74 -0.60 2.91E-06 12.56
13 CXorf34 NM_024917 methyltransferase activity -1.68 1.11E-11 26.08 -0.67 1.08E-05 10.82
14 SKP2 NM_005983 protein binding -1.18 1.80E-11 25.33 -0.74 7.49E-08 17.28
15 IL6ST NM_002184 interleukin-6 receptor activity;protein binding -1.20 2.92E-11 24.72 -0.57 3.49E-06 12.27
16 C10orf119 NM_024834 hypothetical protein -1.14 3.13E-11 24.63 -0.26 5.18E-03 2.29
17 LARS2 NM_015340 leucine-tRNA ligase activity;ATP binding -1.18 5.29E-11 23.85 -0.49 2.65E-05 9.59
18 NR1D2 NM_005126 transcription factor activity -1.12 5.63E-11 23.71 -0.32 1.36E-03 4.11
19 ACSL4 NM_022977 long-chain-fatty-acid-CoA ligase activity -1.22 6.44E-11 23.51 -0.47 7.21E-05 8.21
20 CCD25 NP_060716 unknown -1.09 1.72E-10 22.18 -0.33 1.67E-03 3.83
upregulated HELA HEK
# name RefSeq molecular function MX p§ BS MX p§ BS
1 ANXA3 NM_005139 diphosphoinositol-polyphosphate phosphatase 2.75 1.13E-15 37.54 0.47 3.89E-05 9.08
2 LOC51149 NM_016175 hypothetical protein 1.29 3.48E-11 24.46 0.29 8.79E-03 1.61
3 DDAH1 NM_012137 hydrolase activity 1.02 1.87E-10 22.07 0.35 5.88E-04 5.27
4 UBP18 NM_017414.2 ubiquitin thiolesterase activity 1.00 1.99E-10 21.99 0.54 4.64E-06 11.91
5 IL15RA NM_002189 interleukin receptor activity 1.01 2.06E-10 21.94 0.30 2.38E-03 3.34
6 SPHK1 NM_021972 calmodulin binding;transferase activity 1.01 2.16E-10 21.88 0.42 9.44E-05 7.85
7 HIST1H2AC NM_003512.3 DNA binding 1.27 2.49E-10 21.68 0.54 7.94E-05 8.08
8 MAG1 NM_032717 acyltransferase activity 0.95 2.70E-10 21.53 0.40 1.21E-04 7.53
9 SAT1 NM_002970 acyltransferase activity 1.08 3.21E-10 21.24 0.45 1.46E-04 7.25
10 PTGS2 NM_000963 peroxidase activity;oxidoreductase activity 1.25 4.65E-10 20.78 0.38 3.44E-03 2.84
11 HDHD1A NM_012080 catalytic activity 0.95 8.31E-10 20.03 0.35 8.84E-04 4.67
12 STAMBPL1 NM_020799 ubiquitin thiolesterase activity 0.80 9.32E-10 19.90 0.30 8.23E-04 4.78
13 PIGL NM_004278 hydrolase activity 0.83 1.17E-09 19.61 0.36 2.10E-04 6.73
14 CLPB NM_030813 nucleoside-triphosphatase activity 0.81 2.28E-09 18.74 0.28 3.67E-03 2.75
15 SMPDL3B NM_014474 hydrolase activity, acting on glycosyl bonds 0.88 2.40E-09 18.67 0.33 1.45E-03 4.02
16 HERC6 NM_017912 ubiquitin-protein ligase activity;GEF activity 0.81 2.69E-09 18.52 0.43 5.32E-05 8.62
17 GLRB NM_000824 inhibitory glycine receptor,CNS 0.79 4.31E-09 17.90 0.28 3.47E-03 2.82
18 HHLA3 NM_007071 unknown 0.73 5.02E-09 17.71 0.36 1.86E-04 6.89
19 GNPDA1 NM_005471 hydrolase activity 0.63 2.46E-08 15.68 0.36 1.54E-04 7.17
20 PLEKHA7 NM_175058 unknown 0.63 3.29E-08 15.32 0.28 1.97E-03 3.59
X log2 expression ratio, § adjusted p value, S B statistics (for details see Methods and Additional file 5)
Table 2: Sequences of the most commonly used control siRNA against GFP
company RNAi molecule target gene sequence 5'-3'
Ambion siRNA GFP/eGFP CAA GCU GAC CCU GAA GUU CTT
Qiagen siRNA GFP/eGFP CAA GCU GAC CCU GAA GUU CTT
Dharmacon siRNA GFP I G CAA GCU GAC CCU GAA GUU CBMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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Off-target effects recur in 3/4 different cell lines and are independent of preparation protocols Figure 2
Off-target effects recur in 3/4 different cell lines and are independent of preparation protocols. (a) After transfec-
tion of the siRNA directed against GFP, expression of the genes CYLD and SOAT was measured with qPCR in different cell lines 
after 48 h. As negative controls, a siRNA directed against a candidate tumour supressor gene (siRNA1) was transfected and a 
mock transfection was performed. Values are normalized to mock and the median of 2 housekeeping genes. (b) 2 different 
siRNA molecules with the same target sequence but of different methodological origin were transfected, one generated by in 
vitro transcription (see Methods) and a second siRNA was obtained by oligonucleotide synthesis (Table 1). After transfection, 
the expression of CYLD and SOAT was measured in HEK and HeLa cells and normalized expression after mock transfection and 
the median of 2 housekeeping genes (PGK, DCTN2).BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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[14,15], which was not induced after transfection of 38
nM siRNA molecule (Figure 3). Therefore, the off-target
deregulation of CYLD and SOAT is not dependent on the
methodological origin of the RNAi molecule.
Distinct off-target effects depend on the concentration of 
GFP siRNA
In order to assess specificity of the observed off-target
effect, we transfected increasing amounts of the siRNA
directed against GFP and measured expression of CYLD
and  SOAT  as off-target genes and of C13ORF1  and
LMNB1 as non-regulated, negative controls using qPCR
(Figure 3a, b). In addition, in order to detect induction of
unspecific antiviral interferon response,OAS1 was meas-
ured in transfected cells. As expected, increasing amounts
of transfected GFP siRNA did not have any influence on
the expression level of the genes C13ORF1 and LMNB1
that were used as negative controls. In contrast, the mRNA
levels of CYLD  and  SOAT  decreased with increasing
amounts of transfected GFP siRNA, pointing to targeted
down regulation of these genes by the GFP siRNA both in
HeLa (Figure 3a) and HEK cells (Figure 3b). Furthermore,
knock down of CYLD and SOAT mRNA correlated with
the concentration of the transfected siRNA
(0.718<R2<0.900). Thus, the off-target effect for CYLD
and  SOAT  is dependent on the amount of transfected
siRNA against GFP  in HEK and HeLa cells, supporting
selectivity of the observed effect. In contrast, levels of
C13ORF1 and LMNB1 mRNA did not correlate with the
amount of transfected GFP  siRNA (0.000<R2<0.353).
Transfection of increasing amounts of siRNA molecules
induced the non-specific antiviral interferon response in
HEK cells as reported previously [16], while Hela cells
were unable to mount this response, as expected [17].
However, the interferon response in HEK cells was only
induced using 500 ng (54 nM) of transfected siRNA, a
concentration at least one order of magnitude higher than
the siRNA concentration at which we observed the
sequence-specific knockdown of CYLD and SOAT.
mRNAs deregulated by GFP siRNA cannot be functionally 
attributed to a single cellular process
In general, siRNA molecules can impact on target mRNAs
via two pathways: while imperfect matching mRNA mol-
ecules are impeded mostly in their translation, perfect
matches lead to mRNA degradation [18]. To determine
the mechanism of how the GFP siRNA affects the mRNA
transcript and also to define the set of target genes of the
GFP siRNA, we transfected HeLa and HEK cells with the
siRNA directed against GFP and analyzed transcriptional
changes on an additional second set of expression micro-
arrays. Overall, 397 genes were significantly deregulated
compared to the mock transfection (Table 1, for a com-
plete list see Additional file 2). Intriguingly, a similar
number of genes was significantly over- (190, 48%) and
underrepresented (207, 52%), which means that a large
number of transcripts changed their levels due to second-
ary indirect effects. Next, we wanted to find out whether
the majority of mRNAs were deregulated indirectly due to
direct modulation of a single cellular pathway or tran-
scription factor. As can be seen from the function of dereg-
ulated genes (Table 1, Additional file 2), the deregulated
mRNAs belong to a diverse set of cellular pathways. This
excludes that the off-target effects that we see are due to
deregulation of a single central biochemical pathway.
Down regulation of off-target genes correlates with very 
short stretches of perfect sequence homology
In order to find common motifs in the sequences of target
genes deregulated by the GFP siRNA, we looked at the sec-
ond set of expression profiling experiments that was ded-
icated only to the characterization of off-target-effects of
GFP siRNA. To this end, we analyzed the sequences of 207
genes that were significantly down regulated after trans-
fection of GFP siRNA (see Additional file 2) for sequence
homology to the GFP siRNA sense and antisense mole-
cules (Figure 4). Since upregulation of genes is probably
not due to direct targeting by the siRNA via sequence
homology but rather likely a secondary effect, we focused
in our statistical analysis on genes that were down regu-
lated by the GFP  siRNA. To this end, we aligned the
sequences of the 207 down regulated mRNAs to the GFP
siRNA sequence in order to identify likely direct targets. In
our set of 207 significantly underrepresented mRNAs, we
found 50 mRNAs with an 8 mer homology to the sense
and 88 to the antisense GFP siRNA (116/207 down regu-
lated genes, 56%, Figure 4). Of these mRNAs, 22 showed
homology for both siRNA molecules albeit at different
sequence positions. In order to find out whether this con-
comitant binding of both sense and antisense siRNA mol-
ecules would result in a more pronounced down
regulation of mRNA molecules with homologies for both
siRNAs, we tested whether these mRNAs would be under-
represented to a greater extent in our microarray analyses.
However, no significant down regulation of these 22
mRNAs could be detected compared to the remaining
mRNAs with only one sequence homology. This could of
course be due to the limitation of scoring only perfect
matches and disregarding homologies with single mis-
matches, which reportedly plays a major role in the siRNA
silencing mechanism [19]. In order to assess whether the
homologies detected in our set of underrepresented
mRNAs could also occur by chance, we performed the
same homology searches with shuffled GFP  sense and
antisense sequences. Compared to the proper sequences,
we found significantly less homologies using these shuf-
fled GFP sequences (p < 0.05 for matches > 7 bp and p <
0.002 for matches >8 bp; Figure 4).BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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Degree of off-target knock down of CYLD and SOAT correlates with the concentration of the transfected siRNA Figure 3
Degree of off-target knock down of CYLD and SOAT correlates with the concentration of the transfected 
siRNA. (a) Different concentrations of the siRNA directed against GFP were transfected in HeLa and (b) HEK cells. Expression 
of specific off-target genes (CYLD, SOAT), non-target genes used as negative control (LMNB1, C13ORF1) and genes unspecifically 
upregulated by antiviral cellular response (OAS1) were measured by qPCR 48 h post-transfection. Expression values were nor-
malized to the average of 2 housekeeping genes (PGK, DCTN2). Correlation coefficients between the amount of siRNA trans-
fected and the corresponding mRNA levels of the genes measured are given.BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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In order to exclude a bias due to composition of dinucle-
otides in the siRNA sequences, we additionally shuffled
the GFP siRNA sequence while preserving its dinucleotide
composition and also found less sequence homologies as
compared to the proper GFP  siRNA sequence, even
though the difference was not as pronounced (see Addi-
tional file 3). Therefore, preservation of dinucleotide com-
position seems to retain a low level of homology to the
genes deregulated by the GFP siRNA. Also we searched for
sequence homologies of the proper GFP siRNA sequences
in a set of mRNA sequences that were not deregulated in
our experiments or that were randomly picked. With
increasing length of homology, relatively more homolo-
gies were found with the proper, non-shuffled GFP siRNA
in the set of actually deregulated genes as compared to all
negative controls (see Additional file 3).
Next we wanted to determine whether there was a cluster-
ing of sequence homologies in specific regions of the
siRNA or mRNA molecules. In contrast to previous find-
ings [20], we found no enrichment of sequence homology
of the siRNA sequences neither in the 3'UTR of deregu-
lated mRNA sequences nor anywhere else in the tran-
scripts. Rather, the siRNA of GFP  shows sequence
homology to all parts of candidate target mRNAs (data
not shown). Also, we did not find enrichment of sequence
homology in the 5'seed region of the siRNA molecule.
Discussion
RNA interference is a potent method of gene silencing that
has rapidly become important over the past years and that
is now widely used for experimental as well as therapeutic
purposes. However, the method harbours several pitfalls,
one of them being the artefactual dysregulation of non-
mRNAs deregulated by GFP siRNA contain short sequences perfectly matched to the sense or antisense strand of GFP siRNA Figure 4
mRNAs deregulated by GFP siRNA contain short sequences perfectly matched to the sense or antisense 
strand of GFP siRNA. In order to shed light on the molecular mechanism of sequence-specific off-target effects, we analyzed 
the mRNAs modulated after transfection of GFP siRNA for sequence homology to the transfected siRNA molecules. The 
number of perfect matches with a homology length of at least 8 bp was significantly higher using the proper GFP siRNA 
sequences as compared to the shuffled siRNA sequences.BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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target genes. This effect can either be due to i) induction
of the interferon response in mammalian cells after trans-
fection of RNAi molecules or ii) result from the unin-
tended targeting of genes that have only low level of
sequence homology to the RNAi molecule. While the
former unwanted effect is avoidable, the latter artefact
cannot be predicted. This means that even siRNAs with no
predicted physiological target sequences – which are often
used as negative controls for RNAi experiments – will have
specific off-target effects, and these are thought to be
caused by sequence similarity of very short seed sequences
[13,20]. This has prompted calls for rigorous standards in
siRNA experiments, especially in large-scale screens [10].
Here, we show that siRNA molecules that are commer-
cially distributed and used widely as negative controls
actually target endogenous genes with important roles in
several pathways, even though there are only very small
regions of sequence homology between the siRNA and the
mRNA molecules.
We used siRNA directed against GFP as negative control in
a series of unrelated knock down experiments that were
analyzed by expression microarrays (manuscript in prep-
aration). Due to the ongoing discussion concerning the
specificity of RNAi molecules, we rigorously screened the
data and paid special attention to genes that were com-
monly deregulated in all of these expression profiling
experiments, which were unrelated except for the use of
GFP siRNA as negative control. Indeed, we detected strong
dysregulation of the genes CYLD and SOAT in all of these
experiments (Figure 1a) and in various cell lines (Figure
2a). Only EVSAT cells did not show a reduced expression
of CYLD and SOAT after transfection of GFP siRNA. This
is probably due to the lower transfection efficiency of
EVSAT cells compared to HEK, HeLa or U2OS cells. Fur-
thermore, we show that the strong dysregulation of CYLD
and SOAT is independent of the synthetic origin of the
siRNA molecules (Figure 2b). Therefore, the commonly
used siRNA directed against GFP has sequence-dependent
off-target effects in human cells, with the genes CYLD and
SOAT showing most pronounced deregulation.
Are these effects sequence-dependent or caused by
sequence-independent effects? In general, unwanted
effects like activation of the interferon response are more
likely to occur when high concentrations of siRNA are
used. How low the concentration of transfected dsRNA
molecules must be to prevent unspecific effects is contro-
versial: While there are reports that siRNA concentrations
of ≤ 20 nM usually do not lead to induction of the inter-
feron response [21], others have detected unspecific
effects using siRNA concentrations as low as 10 nM [15].
In this study, we transfected increasing amounts of siRNA
directed against GFP (Figure 3). In HEK as well as in HeLa
cells, we could show that off-target knock down of CYLD
and SOAT correlates with the concentration of the trans-
fected siRNA. Already a concentration of 5 nM siRNA
showed the down regulation of CYLD and SOAT as off-
target genes. At the same time, the interferon response is
activated only after transfection of more than 54 nM
siRNA, pointing to a directed targeting of CYLD and SOAT
and not a down regulation which is concomitant to the
interferon response mechanism. In order to shed light on
this gene-specific mechanism, we performed a genome-
wide screen to identify all mRNA transcripts deregulated
by the GFP  siRNA. Intriguingly, we found a similar
number of mRNAs overrepresented as mRNAs underrep-
resented after transfection of GFP siRNA, which means
that at least half of the deregulation that we detected is
due to secondary effects. An earlier study could not detect
off-target effects for a siRNA directed against GFP [22]. In
the light of the recent progress of the field and several
reports on off-target effects, this finding seems highly
unlikely since the majority of siRNA molecules, even
those with a non-physiological target, will be able to pair
to a set of mRNAs with partial homology. In fact, we
reproducibly found a large number of genes specifically
deregulated after transfection of GFP siRNA.
In order to shed light on the mechanism of action of the
GFP siRNA, we looked for sequence homologies between
the GFP siRNA and the deregulated mRNAs. In our set of
mRNAs that were underrepresented after transfection of
GFP  siRNA, we found significantly more hits with the
proper GFP siRNA sequence as compared to the shuffled
siRNA sequences for sequence homologies of more than 7
bp length. Of the 207 genes down modulated, we found
perfect matches of more than 7 bp in 116 (56 %) of the
down modulated genes. 22 mRNAs showed homology to
both the sense strand as well as the antisense strand of the
GFP siRNA.
In contrast to the current model where binding of several
siRNA molecules results in more consistent down modu-
lation of the mRNA [23], we did not find these 22 mRNAs
to be more underrepresented as compared to the mRNAs
with homologies to one of the siRNA molecules only. This
could be due to our scoring of perfect, non-mismatch
homologies only due to computational limitations [10].
Interestingly, in our system both strands of the transfected
double-stranded siRNA duplex show a significant number
of homologies to the underrepresented mRNAs as com-
pared to the shuffled control sequences. While there is a
bias towards usage of the antisense strand as required,
both strands of the siRNA are loaded into the RISC com-
plex. This could be reduced by proper design of the GFP
siRNA sequence which would prevent loading of both
sense and antisense molecules into the RISC complex
[24]. Down regulation of the remaining 91 (44 %) tran-
scripts without perfect matches to the siRNA sequences isBMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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probably due to pairing with partial mismatches, whose
in-silico prediction is almost impossible [10]. Addition-
ally, a proportion of these remaining 44 % of deregulated
mRNAs without perfect match to GFP siRNA is also likely
to be modulated indirectly as secondary effect, just as the
190 mRNAs that are up regulated after transfection of the
siRNAs. While the indirect target mRNAs may be of little
interest for the molecular mechanism, these secondary
effects will be just as confounding in experiments using
GFP siRNA as the direct effects. According to our data,
possibly as many as 14 % of sequence-specific off-target
effects could be avoided by design in order to exclude one
of the two strands of the transfected siRNA from the RISC
complex [9,8]. Very recently, several vendors introduced a
new generation of chemically modified siRNAs that are
supposed to ensure loading of the siRNA antisense strand
into the RISC complex only, thereby reducing off-target
effects.
With increasing length of homology, relatively more hits
were scored for the proper, non-shuffled GFP siRNA in the
set of actually deregulated genes as compared to all nega-
tive controls (Figure 4; Additional file 3). It is remarkable
that preservation of dinucleotides while shuffling of GFP
siRNA sequence results in a larger number of sequence
homologies in deregulated genes. It seems that the dinu-
cleotides in the GFP siRNA sequence have a background
homology in human genes, which is abrogated by com-
plete shuffling of the dinucleotide composition.
Interestingly, in contrast to previous findings [13,20],
homologous sequences were not clustered in the 5' seed
sequence of the GFP siRNA and they were also not clus-
tered in the 3'UTR of target mRNAs or any other region of
the mRNA. In Jackson et al., [13], the authors performed
transcriptome-wide time course analyses to identify off-
target mRNA transcripts, which allowed limiting the
number of primary off-target genes to 9 only. Within these
9 genes, the authors could search for regions with only
partial and very small homology (e.g. 5/11 bp identities).
In contrast, we could only analyze a single time point and
found 207 down modulated genes, which is why we had
to restrict our homology search to perfect matches only,
and this could be a confounding factor.
How to handle sequence-specific off-target effects in
siRNA experiments? Proper design of the sequence of siR-
NAs using in-silico target gene prediction will not avoid
down regulation of off-target mRNA transcripts as shown
here and discussed previously [10]. The aim should there-
fore not be to avoid these effects but rather to identify false
positives and exclude them from the set of deregulated
mRNAs. In order to help identify false positive target
genes that really are off-target genes in future knock-down
experiments, we here present the endogenous genes that
are down regulated by one of the most commonly used
control siRNA directed against GFP. Another strategy to
identify off-target genes arising from the control siRNA is
to use several different control siRNAs which are directed
against different sites in non-endogenous genes like green
fluorescent protein and Luciferase in addition to a mock
transfected control. Also, the sequence of the siRNA
directed against the gene of interest could be scrambled
and the resulting molecule be used as a negative control.
However, the most straightforward approach is to employ
several different siRNA molecules to target the mRNA of
interest and identify true targets by their property of being
knocked-down by all of these siRNAs [25]. The most com-
prehensive approach of this kind would be to use esiR-
NAs, which should then be produced from the whole
target mRNA sequence. In this case, while all of the result-
ing esiRNA molecules would target the single mRNA of
interest, the off-target effects of the single esiRNA that are
present only at very low concentrations compared to all
other esiRNA molecules would be minimal and probably
below detection level. Furthermore, the transfection of
shRNA plasmids by lenti- or retroviruses is an option for
reducing off-target effects, since the level of stable shRNA
expression is comparatively modest which results in min-
imal off-target effects. A second more laborious approach
is to rescue the observed siRNA phenotype by transfecting
a recombinant cDNA that is mutated at the siRNA target
sequence(s) and thus rendered non-responsive to the
siRNA. Alternatively, after using a siRNA directed against
the 3'UTR of a certain gene, rescue of expression can be
achieved by expression of the mRNA lacking its normal
3'UTR sequence. Ideally, both approaches of i) the usage
of several siRNA molecules and ii) rescue of the pheno-
type by non-responsive cDNA plasmids should be com-
bined in experimental strategies. Only these precautions
will allow to definitely exclude that the observed pheno-
type of the siRNA knockdown is due to unwanted artefac-
tual off-target effects.
Conclusion
Our analysis shows that even a siRNA frequently used as
negative control that is directed against exogenous GFP
has off-target effects in mammalian cells. This siRNA is
distributed by several companies and widely used for
RNAi experiments. Since off-target effects seemingly can-
not be avoided, the best strategy is to identify these off-tar-
get genes as false positives and exclude them from the set
of deregulated mRNAs. In addition to proving that a
siRNA used as a negative control has sequence specific off
target effects, we also provide a list of deregulated target
genes of the exogenous GFP siRNA that can be used as ref-
erence for future RNAi experiments.BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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Methods
Cell lines
HEK293, HeLa, U2OS and EVSAT cells were obtained
from ATCC and were maintained in DMEM containing
10% fetal bovine serum (FBS) and 1% antibiotics at 37°C
in a humidified atmosphere containing 5% CO2. Cells
were passaged every 3–4 days.
siRNA design and synthesis via in vitro transcription
For the design of effective siRNA target sequences, a siRNA
design tool was used [26] and siRNA target sequences
were chosen according to published criteria [27,9,8].
For synthesis of siRNAs via in vitro transcription, the
Silencer™ siRNA Construction Kit (Ambion, Austin, USA)
was used with modifications [28].
Chemically synthesized GFP  siRNA was obtained from
Ambion (Ambion, Austin, USA).
siRNA transfection and RNA isolation
Transient transfection of cells was performed with Effect-
ene transfection reagent (Qiagen, Hilden, Germany)
according to the manufacturer's protocol. For transfection
in a 48-well format, we used reagents suggested for a 24-
well transfection to increase efficiency. In order to exclude
artefacts due to this change in procedure, control experi-
ments were treated in exactly the same way. 6–8 h after
transfection, medium was replaced. Afterwards, cells were
incubated under normal growth conditions and harvested
48 h after transfection. If not mentioned differently, siR-
NAs were transfected with a concentration of 38 nM,
which corresponds to 350 ng siRNA employed per 48-well
reaction.
RNA was isolated from cell pellets frozen at -80°C using
the Absolutely RNA Micro Prep Kit (Stratagene, La Jolla,
USA). For array experiments, cell pellets were resuspended
in Trizol (Invitrogen, Karlsruhe, Germany), total RNA
extracted according to the protocol and further purified
on Rneasy Mini spin columns (Qiagen, Hilden, Ger-
many).
Transcriptome amplification and labelling for microarray 
experiments
Amplification of sample RNA was done according to the
TAcKLE protocol with modifications [29]. Briefly, 2 μg
total RNA was employed in first- and second-strand cDNA
synthesis. Double-stranded cDNA was extracted, dis-
solved in 10 μl nuclease-free water and employed for in
vitro transcription using RiboMAX Large Scale RNA Pro-
duction System T7 (Promega, Karlsruhe, Germany)
according to the manufacturer's recommendations in 40
μl reaction volume for 12 h. Samples were labelled with
fluorochrome as described previously [29].
Hybridization of oligo-microarrays
A set of 36,196 gene-specific 70 mer oligonucleotides
(Human Oligo Set 4.0; Operon, Cologne, Germany) was
printed in unicates on glass slides coated with epoxy-
silane (Schott Nexterion, Jena, Germany).
After completion of the labelling reactions, control and
sample cDNA was combined and purified on Microcon
YM-30 filter columns (Millipore, Schwalbach, Germany)
as suggested by the manufacturer. For blocking of repeti-
tive sequence elements, 25 μg Cot-1 DNA (Roche Diag-
nostics, Mannheim, Germany), 25 μg poly-A RNA (Sigma-
Aldrich, Munich, Germany) and 75 μg yeast tRNA (Sigma-
Aldrich, Munich, Germany) were added before the final
washing step. Just prior to hybridization, slides were
washed for 2 min in 0.2% SDS (w/v), 2 min in ddH2O at
RT and 2 min in boiling ddH2O (95°C), followed by 1
min centrifugation at 1000 rpm. Purified dye-labeled
cDNA was mixed with 140 μl Ultra-Hyb hybridization
buffer (Ambion, Austin, USA), agitated for 60 min at
60°C and for 10 min at 70°C and subsequently applied
to pre-heated (60°C) microarrays mounted in a GeneTAC
Hybridization Station (Genomic Solutions, Ann Arbor,
USA). Hybridization reactions were performed for 40 h at
42°C with gentle agitation. Thereafter, arrays were auto-
matically washed at 36°C with 0.5× SSC, 0.1% (w/v) SDS
for 5 min; 0.05× SSC, 0.1% (w/v) SDS for 3 min; 0.05×
SSC for 20s and 0.05× SSC, 0.1% (w/v) Tween20 for 20s.
Flow time was set to 40s. Immediately after completion of
the final wash step, arrays were collected, immersed in
0.05× SSC, 0.1% (w/v) Tween20 for transportation and
dried by centrifugation in 50 ml Falcon tubes for 3 min at
2500 rpm.
Data acquisition of microarray experiments, quality 
control and normalization
Hybridized microarrays were scanned at 5 μm resolution
and variable PMT voltage to obtain maximal signal inten-
sities with < 0.1% probe saturation, a count ratio of 0.8–
1.2 (Cy5/Cy3) and maximal congruence of histogram
curves using a GenePix 4000B microarray scanner (Axon
Instruments, Union City, USA). Data summaries of the
spot intensities were provided by GenePix Pro, Version
5.1 (Axon Instruments, Union City, USA) using local
background correction and including mean and the
median pixel intensities at each wavelength for both fea-
ture and background pixels.
For quality control of individual spots, boolean quality
flag information was given by GenePix Pro pre-process-
ing. Additionally, spots were dismissed if either the fea-
ture to background ratio of the median intensity values at
both wavelengths were less than 1.5 or the absolute log2
ratio of the mean and median feature intensity varied by
more than 0.25 for at least one wavelength. For all statis-BMC Molecular Biology 2008, 9:60 http://www.biomedcentral.com/1471-2199/9/60
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tical analyzes, the log2 ratio of the median spot feature
intensity at wavelength 635 (Cy5) and 532 (Cy3) was
used.
Normalization of spot intensities was performed by vari-
ance stabilizing transformation, which calibrates for sam-
ple-to-sample variations through shifting and scaling and
transforms the intensities to a scale where the variance is
approximately independent of the mean intensities [30].
The procedure provides normalized intensities on a log2
scale. Log2 expression ratios (M-values) were obtained by
subtracting the transformed intensities at both scanned
wavelengths.  In detail, normalization was performed as
described in Additional file 5.
The 20 most deregulated genes after transfection of siRNA
directed against GFP are listed in Table 1. A complete list
of deregulated genes is available (see Additional file 2).
Deregulated genes in both tables are sorted for the
adjusted p value of experiments performed in HeLa cells.
Information about molecular function is based on GO
terms. The M value depicts the degree of deregulation,
while the B value is a measure of significance of the dereg-
ulation. Raw and normalized data are deposited in the
Gene Expression Omnibus database (accession No.
GSE8680) [31].
Real-time PCR quantification
cDNA templates were generated from the corresponding
mRNA using SuperScript II and anchored oligo-d(T)20
primer (Invitrogen, Karlsruhe, Germany). For amplifica-
tion and quantification, SYBR Green ROX Mix (Abgene,
Epsome, UK) was used. To prevent amplification of
genomic DNA, all amplicons were designed to span exon-
exon boundaries and were tested using genomic DNA as
negative control. Real-Time PCR was performed in a
7900RT Fast Real-Time PCR System (Applied Biosystems,
Forster City, USA) with the following settings: initial
denaturation at 95°C for 15 min, amplification and quan-
tification at 95°C, 15s; 60°C, 10s; 72°C, 60s for 40 cycles
with single fluorescence measurement. Products were
analyzed by melting-curve analysis (60°C to 95°C with
0.1K/s continuous fluorescence measurements). Calcula-
tion of efficiency and relative quantification versus non-
regulated standard genes (PGK, DCTN2) were performed
as described previously [32,33]. Error bars depict standard
deviation of duplicate qPCR reactions. Additional file 4
shows used qPCR primer sequences.
Detection of sequence homologies between deregulated 
mRNAs and GFP siRNA
The program FASTA [34] (with parameter settings: word
size 2, gap opening penalty 10, gap extension penalty 10,
no statistics, number of alignments up to 30000) was
used to search for similarities between sequences of dereg-
ulated mRNAs and the siRNA (GFP  or shuffled). This
search is equivalent to the FASTA alignment of the siRNA
or miRNA duplexes with the off-target transcripts used in
[13]. All alignments were filtered for complete identical
oligomers of 8 and more bases, 9 and more bases, etc.
Additionally, the positions of the identical oligomers were
extracted. Using the "cds" field in the annotation of the
Refseq sequences, the region of the 3' UTR of the genes
was defined and determined, whether the homologous
region was located in the 3'UTR. As control genes, we used
207 mRNAs whose expression was not changed in the
experiment and looked for sequence homologies in the
same way (see Additional file 3). To have an appropriate
control for the siRNA we used SHUFFLE (Wisconsin Pack-
age, Accelrys Inc.) to randomize the order of the nucle-
otides in the siRNAs without changing the composition
(Figure 4). In an additional control, the sequences were
randomized so that not only composition, but also dinu-
cleotide content was preserved (see Additional file 3). All
shuffled sequences were then compared with the list of
deregulated and control genes. Different sets of non
deregulated genes were used as negative controls ("not
dereg.A"; "not dereg.B"; "diff.array") that had the same
size of 207 genes as the set of actually down regulated
genes after transfection of GFP siRNA ("dereg."). The first
two control sets contain genes that were not deregulated
after transfection of GFP siRNA in all 8 hybridizations
(M<0.2; "not dereg.A and B"). The third set of genes
("diff.array") were not deregulated (M<0.2) in an addi-
tional unrelated microarray experiment. Error bars depict
standard deviations between sense and antisense
sequences (see Additional file 3).
To compare the sequence of sense and antisense GFP
siRNA molecules with the sequences of the target genes
CYLD (NM_015247) and SOAT (NM_003101), the soft-
ware package SIMILARITY [35] implemented in W2H [36]
was used to find local similarities between the siRNA
sequences and the genes according to Jackson et al., [13].
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